NO880179L - Polymerkomplekser, fremgangsmaate for fremstilling av disse og farmasoeytiske midler inneholdende disse. - Google Patents

Polymerkomplekser, fremgangsmaate for fremstilling av disse og farmasoeytiske midler inneholdende disse.

Info

Publication number
NO880179L
NO880179L NO880179A NO880179A NO880179L NO 880179 L NO880179 L NO 880179L NO 880179 A NO880179 A NO 880179A NO 880179 A NO880179 A NO 880179A NO 880179 L NO880179 L NO 880179L
Authority
NO
Norway
Prior art keywords
group
complex
hydrogen atom
polymer complexes
groups
Prior art date
Application number
NO880179A
Other languages
English (en)
Norwegian (no)
Other versions
NO880179D0 (no
Inventor
Heinz Gries
Julius Deutsch
Erich Klieger
Ulrich Niedballa
Franz-Josef Renneke
Juergen Conrad
Wolfgang Muetzel
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO880179D0 publication Critical patent/NO880179D0/no
Publication of NO880179L publication Critical patent/NO880179L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6887—Antibody-chelate conjugates using chelates for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
NO880179A 1987-01-19 1988-01-18 Polymerkomplekser, fremgangsmaate for fremstilling av disse og farmasoeytiske midler inneholdende disse. NO880179L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873701665 DE3701665A1 (de) 1987-01-19 1987-01-19 Polymer-komplexe, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel

Publications (2)

Publication Number Publication Date
NO880179D0 NO880179D0 (no) 1988-01-18
NO880179L true NO880179L (no) 1988-07-20

Family

ID=6319226

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880179A NO880179L (no) 1987-01-19 1988-01-18 Polymerkomplekser, fremgangsmaate for fremstilling av disse og farmasoeytiske midler inneholdende disse.

Country Status (10)

Country Link
EP (1) EP0277088A2 (da)
JP (1) JPS6454028A (da)
AU (1) AU1064988A (da)
DE (1) DE3701665A1 (da)
DK (1) DK22688A (da)
IE (1) IE880127L (da)
IL (1) IL85139A0 (da)
NO (1) NO880179L (da)
PT (1) PT86572B (da)
ZA (1) ZA88342B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806795A1 (de) * 1988-02-29 1989-09-07 Schering Ag Polymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5681543A (en) * 1988-02-29 1997-10-28 Shering Aktiengesellschaft Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI
GB8900719D0 (en) * 1989-01-13 1989-03-08 Nycomed As Compounds
FR2645862B1 (fr) * 1989-04-18 1991-07-12 Esteve Labor Dr Derives d'isothiazolo-pyrydone azetidinyl substitues, leur preparation et leur application en tant que medicaments
US5384108A (en) * 1989-04-24 1995-01-24 Mallinckrodt Medical, Inc. Magnetic resonance imaging agents
GB8916781D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
DE3938992A1 (de) 1989-11-21 1991-05-23 Schering Ag Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE4017439C2 (de) * 1990-05-30 1994-06-23 Deutsches Krebsforsch Polyethersubstituierte Tumormittel
DE4039920A1 (de) * 1990-12-14 1992-06-17 Basf Ag Neue polyethylenimin- und polyvinylamin-derivate, mit diesen derivaten beschichtete traegermaterialien auf der basis von aluminium sowie deren verwendung zur herstellung von offsetdruckplatten
JP2901787B2 (ja) * 1991-07-15 1999-06-07 日本メジフィジックス株式会社 核磁気共鳴造影剤
JP2894879B2 (ja) * 1991-10-04 1999-05-24 日本メジフィジックス株式会社 診断用造影剤
US5324503A (en) * 1992-02-06 1994-06-28 Mallinckrodt Medical, Inc. Iodo-phenylated chelates for x-ray contrast
EP0664713B1 (en) * 1992-10-14 2000-01-19 Nycomed Imaging As Therapeutic and diagnostic imaging compositions and methods
EP1419786A1 (en) 2002-11-13 2004-05-19 Bracco Imaging S.p.A. Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof
ITPD20030174A1 (it) * 2003-07-31 2003-10-29 Univ Padova Coniugati polimerici per diagnostica e terapia
DE102005039154A1 (de) * 2005-08-17 2007-03-01 GÖPFERICH, Achim, Prof. Dr. Bioabbaubare Polymere für den Transport von Nukleinsäuren in Zellen
WO2021228642A1 (en) 2020-05-12 2021-11-18 Basf Se Use of carboxymethylated polymer of lysines as dispersing agent and compositions comprising the same

Also Published As

Publication number Publication date
DK22688D0 (da) 1988-01-19
JPS6454028A (en) 1989-03-01
PT86572A (de) 1988-02-01
DK22688A (da) 1988-07-20
EP0277088A2 (de) 1988-08-03
IE880127L (en) 1988-07-19
AU1064988A (en) 1988-07-21
ZA88342B (en) 1988-07-04
NO880179D0 (no) 1988-01-18
PT86572B (pt) 1991-12-31
IL85139A0 (en) 1988-06-30
DE3701665A1 (de) 1988-07-28

Similar Documents

Publication Publication Date Title
FI79026C (fi) Diagnostiska medel foer anvaendning i ultraljud-, nmr- och roentgendiagnostik, foerfarande foer deras framstaellning, komplexsalter som innehaolls i dessa och deras anvaendning foer framstaellning av diagnostiska medel.
US4647447A (en) Diagnostic media
JP3179092B2 (ja) 錯生成リガンドを含有するカスケードポリマー、その製造方法および該カスケードポリマーを含有する医薬
US5362475A (en) Gadolinium chelates for magnetic resonance imaging
RU2166501C2 (ru) Каскадные полимерные комплексы, исходные соединения и фармацевтическая композиция
US5914095A (en) Polychelants containg amide bonds
US5681543A (en) Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI
NO880179L (no) Polymerkomplekser, fremgangsmaate for fremstilling av disse og farmasoeytiske midler inneholdende disse.
US5482700A (en) Substituted polyamino, polycarboxy complexing agent dimers for MRI and X-ray contrast
JP3701678B2 (ja) カスケードポリマー錯体、その製造方法及びこれらを含有する医薬
JPH01139555A (ja) 多核の置換錯生成剤、錯体および錯塩、その製造方法、これを含有する医薬、ｎｍｒ‐、ｘ線‐または超音波診断剤、放射線診断剤および放射線治療剤、医薬の製造方法ならびに抗体接合体の製造方法
NO174394B (no) Polymerkompleks bestaaende av minst ett ion av et grunnstoff av ordenstallene 21-29, 42, 44 eller 57-83 og en karboksylsyregruppe- inneholdende kompleksdannende polymer, fremstilling derav, anvendelse derav og diagnostisk middel
JPH04504436A (ja) キーラント
CA2034242A1 (en) Macrocyclic tetraaza compounds containing a six-membered ring, processes for their production, and pharmaceutical agents containing same
US5648063A (en) Sterile composition comprising a chelate complex for magnetic resonance imaging
JP2002507977A (ja) ペルフルオロアルキル含有のオリゴマー化合物、その製造方法およびｎｍｒ診断法におけるその使用
US5560903A (en) Method of enhancing paramagnetism in chelates for MRI
NO314545B1 (no) Kaskadepolymerkomplekser, fremgangsmåter for fremstilling av disse og farmasöytiske midler inneholdende disse
US5693309A (en) Substituted complexing agents, complexes, and complex salts, processes for their production, and pharmaceuticals containing same
US20120064002A1 (en) Enantiomer-pure (4S,8S)- and (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triaza-3N,6N,9N-tricarboxymethyl-1,11-undecanedioic Acid and Derivatives Thereof, Process for their Production and Use for the Production of Pharmaceutical Agents